Egree of expression are important considerations when designing studies to examine the impact of a vector-based intervention upon cellular processes implicated in muscle adaptation, and the morphological attributes of experimentally manipulated muscles. Intramuscular inflammation and degeneration of transduced Licochalcone A biological activity musculature may be caused by priming the immune system to eliminate an introduced antigen, such as the capsid proteins comprising a viral vector particle [27]. Prior exposure of humans and other mammals to wildtype ML-240 chemical information adeno-associated viruses or rAAV vectors can sensitize a host’s immune system to reaction against subsequently administered vectors [28,29]. However we and others have extensively demonstrated that recipients not previously exposed typically tolerate intramuscular administration of rAAV vectors without evidence of cellular damage [17]. Recombinant AAV vectors typically exert very little evidence of adverse effects upon target cells, as they lack the coding regions of their wildtype genome, are derived from wildtype viruses that are notReporter Genes Can Promote Inflammation in Muscleassociated with specific human pathologies, and typically do not promote modification of the host cell’s genome. Our data are consistent with previous findings, as we were able to directly administer rAAV vectors lacking a functional gene (rAAV6:CMVMCS) to murine musculature without causing ensuing cellular damage and inflammation. The 1655472 transduction of skeletal muscles with constructs expressing non-native proteins can also promote an immune reaction and associated tissue damage, as this has been 
demonstrated following intramuscular administration of rAAV vectors [30,31]. However, this response appears to vary depending 1317923 on the gene being expressed, as many other studies (including work of our own) have employed rAAV vectors to successfully transduce mammalian musculature with constructs encoding for non-native genes without observing ensuing tissue damage and inflammation [4,16,32]. In our studies reported here, we have shown similarly well-tolerated expression of non-native transgenes, by using rAAV vectors to express human follistatin-288 in murine skeletal muscles. We have also achieved robust expression of Renilla-derived green fluorescent protein in murine skeletal muscles without evidence of cellular degeneration and inflammation, depending on the vector dose used. Our findings of a positive correlation between rAAV6:hPLAP vector dose and the incidence of inflammation and cellular damage in murine muscles (and a similar correlation albeit requiring higher doses for rAAV6:GFP) suggest that specific gene products may perturb cellular function if expressed at sufficiently high levels. In support of this idea, it has been reported that dosedependent toxic effects can be observed even after expressing muscle-specific transgenes in skeletal muscle via vector based approaches [18]. Some studies have used tissue-specific promoter/ enhancer elements to reduce toxicity in transduced musculature and minimize the potential for unintentional transgene expression from antigen producing cells [19,33,34], whereas others have reported that the use of muscle-specific promoters does not prevent a deleterious reaction [3,35]. The inflammatory response we observed in muscles transduced with hPLAP expression cassettes was less-pronounced at early time-points when the CMV promoter was substituted with a muscle-specific, creatine kinase-derived promoter (CK6).Egree of expression are important considerations when designing studies to examine the impact of a vector-based intervention upon cellular processes implicated in muscle adaptation, and the morphological attributes of experimentally manipulated muscles. Intramuscular inflammation and degeneration of transduced musculature may be caused by priming the immune system to eliminate an introduced antigen, such as the capsid proteins comprising a viral vector particle [27]. Prior exposure of humans and other mammals to wildtype adeno-associated viruses or rAAV vectors can sensitize a host’s immune system to reaction against subsequently administered vectors [28,29]. However we and others have extensively demonstrated that recipients not previously exposed typically tolerate intramuscular administration of rAAV vectors without evidence of cellular damage [17]. Recombinant AAV vectors typically exert very little evidence of adverse effects upon target cells, as they lack the coding regions of their wildtype genome, are derived from wildtype viruses that are notReporter Genes Can Promote Inflammation in Muscleassociated with specific human pathologies, and typically do not promote modification of the host cell’s genome. Our data are consistent with previous findings, as we were able to directly administer rAAV vectors lacking a functional gene (rAAV6:CMVMCS) to murine musculature without causing ensuing cellular damage and inflammation. The 1655472 transduction of skeletal muscles with constructs expressing non-native proteins can also promote an immune reaction and associated tissue damage, as this has been demonstrated following intramuscular administration of rAAV vectors [30,31]. However, this response appears to vary depending 1317923 on the gene being expressed, as many other studies (including work of our own) have employed rAAV vectors to successfully transduce mammalian musculature with constructs encoding for non-native genes without observing ensuing tissue damage and inflammation [4,16,32]. In our studies reported here, we have shown similarly well-tolerated expression of non-native transgenes, by using rAAV vectors to express human follistatin-288 in murine skeletal muscles. We have also achieved robust expression of Renilla-derived green fluorescent protein in murine skeletal muscles without evidence of cellular degeneration and inflammation, depending on the vector dose used. Our findings of a positive correlation between rAAV6:hPLAP vector dose and the incidence of inflammation and cellular damage in murine muscles (and a similar correlation albeit requiring higher doses for rAAV6:GFP) suggest that specific gene products may perturb cellular function if expressed at sufficiently high levels. In support of this idea, it has been reported that dosedependent toxic effects can be observed even after expressing muscle-specific transgenes in skeletal muscle via vector based approaches [18]. Some studies have used tissue-specific promoter/ enhancer elements to reduce toxicity in transduced musculature and minimize the potential for unintentional transgene expression from antigen producing cells [19,33,34], whereas others have reported that the use of 
muscle-specific promoters does not prevent a deleterious reaction [3,35]. The inflammatory response we observed in muscles transduced with hPLAP expression cassettes was less-pronounced at early time-points when the CMV promoter was substituted with a muscle-specific, creatine kinase-derived promoter (CK6).